Valeant Pharma (NYSE: VRX) has priced its previously announced registered offering of common shares in the United States (the "Offering") ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE